INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M$138K
7,562 sh
Jan 20, 2026
Page 1425 of 1790
← PrevNext →
Jan 22, 2026
traded Jan 20, 2026
+2d
SEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
10.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$107K
15.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CL
Chapman Steven LeonardDirector, CEO AND PRESIDENT
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
3,386 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Sheena JonathanDirector, CO-FOUNDER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
191 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
13.9K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
32.7K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
1,522 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

62
BE
Brakewood Harold EugeneChief Business Officer
IMRXImmuneering Corp
Open-market purchase
BUY$25K
5,250 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

52
ML
Marantz Jing L.CHIEF MEDICAL OFFICER
SRRKScholar Rock Holding Corp
Open-market sale
SELL$258K
5,798 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
HJ
Ho JunlinGENERAL COUNSEL
SRRKScholar Rock Holding Corp
Open-market sale
SELL$357K
8,016 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
PC
Parlavecchio CarynCHRO
SRRKScholar Rock Holding Corp
Open-market sale
SELL$294K
6,600 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$15.09M
12.9K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Open-market sale
SELL$374K
8,406 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

45
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$6.46M
5,514 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

45
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$9.54M
8,139 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

36
AA
Attal AlainDirector
GMEGameStop Corp.
Open-market purchase
BUY$260K
12.0K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

35
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Option exercise
M$13.89M
27.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

34
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$590K
503 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

33
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$269K
10.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

31
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

30
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Tax withholding
F$202K
27.2K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

30
EH
Exicure HiTron Inc.10% Owner
XCUREXICURE, INC.
Open-market sale
SELL$1.16M
258.4K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence